Back

Independent and cumulative prognostic information of C-reactive protein and interleukin-6 to predict major adverse cardiovascular events and death in post acute coronary syndrome patients

31 August 2025 (11:15 - 11:25)
Organised by: Logo
Congress Presentation Part of: Determinants of long-term outcome following acute myocardial infarction Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Temporal trends of 1-year mortality and its determinants in patients with acute myocardial infarction in England and Wales: a population-based cohort study over 15 years: 2005-2019
Miss S. Ayayo (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
The role of lipoprotein(a) in myocardial damage and 1-year clinical outcomes after ST-segment elevation myocardial infarction
Doctor Y. Zhou (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Eighteen-year trends in cardiovascular risk and mortality in patients with acute coronary syndrome without ST-segment elevation
Doctor K. Olesen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Short-term exposures to air pollutants affect mitochondrial DNA copy number in patients with acute coronary syndromes.
Doctor G. Gazzaniga (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Determinants of long-term outcome following acute myocardial infarction
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Session
Determinants of long-term outcome following acute myocardial infarction
thumbnail
Congress Session
Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction
thumbnail
Congress Session
Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources